SMO and neoplasm: Since the HH pathway contributes to the development of the dense stromal tissue, several studies combined SMO inhibitors with either cytotoxic chemotherapeutic drugs [76,77,78] or a targeted antibody [79] to increase the delivery of the drugs and promote tumor infiltration of the CD8 T cells.